Influence of the Nonergot Dopamine Agonist Piribedil on Vigilance in Patients With Parkinson Disease and Excessive Daytime Sleepiness (Pivicog-Pd): An 11-Week Randomized Comparison Trial Against Pramipexole and Ropinirole.

Clinical neuropharmacology

PubMedID: 24992083

Eggert K, Ohlwein C, Kassubek J, Wolz M, Kupsch A, Ceballos-Baumann A, Ehret R, Polzer U, Klostermann F, Schwarz J, Fuchs G, Jost W, Albert A, Haag A, Hermsen A, Lohmüller K, Kuhn K, Wangemann M, Oertel WH, In cooperation with the German Competence Network on Parkinson’s Disease. Influence of the Nonergot Dopamine Agonist Piribedil on Vigilance in Patients With Parkinson Disease and Excessive Daytime Sleepiness (Pivicog-Pd): An 11-Week Randomized Comparison Trial Against Pramipexole and Ropinirole. Clin Neuropharmacol. 2014;.
An abstract is not available. Please access the article through the links below.